HUP9903810A2 - Ciklopeptidszármazékok - Google Patents
CiklopeptidszármazékokInfo
- Publication number
- HUP9903810A2 HUP9903810A2 HU9903810A HUP9903810A HUP9903810A2 HU P9903810 A2 HUP9903810 A2 HU P9903810A2 HU 9903810 A HU9903810 A HU 9903810A HU P9903810 A HUP9903810 A HU P9903810A HU P9903810 A2 HUP9903810 A2 HU P9903810A2
- Authority
- HU
- Hungary
- Prior art keywords
- substd
- opt
- amino
- methyl
- acid residue
- Prior art date
Links
- 125000000217 alkyl group Chemical group 0.000 abstract 3
- 125000001475 halogen functional group Chemical group 0.000 abstract 3
- FZWLAAWBMGSTSO-UHFFFAOYSA-N Thiazole Chemical compound C1=CSC=N1 FZWLAAWBMGSTSO-UHFFFAOYSA-N 0.000 abstract 2
- 125000003545 alkoxy group Chemical group 0.000 abstract 2
- 150000001735 carboxylic acids Chemical group 0.000 abstract 2
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 abstract 2
- 229920002554 vinyl polymer Polymers 0.000 abstract 2
- VDCLCAXYTCLVQY-CTVGSUQISA-N 2-[(3s,6s,9s,15s,18s,21s,24s,27s)-15,18-di(butan-2-yl)-6-[(4-methoxyphenyl)methyl]-3,10,16,19,22,28-hexamethyl-2,5,8,11,14,17,20,23,26,29-decaoxo-9,24,27-tri(propan-2-yl)-1,4,7,10,13,16,19,22,25,28-decazabicyclo[28.4.0]tetratriacontan-21-yl]acetic acid Chemical compound C([C@H]1C(=O)N[C@@H](C)C(=O)N2CCCCC2C(=O)N(C)[C@@H](C(C)C)C(=O)N[C@H](C(=O)N(C)[C@@H](CC(O)=O)C(=O)N(C)[C@@H](C(C)CC)C(=O)N(C)[C@H](C(NCC(=O)N(C)[C@@H](C(C)C)C(=O)N1)=O)C(C)CC)C(C)C)C1=CC=C(OC)C=C1 VDCLCAXYTCLVQY-CTVGSUQISA-N 0.000 abstract 1
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical group OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 abstract 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 abstract 1
- CZCIKBSVHDNIDH-NSHDSACASA-N N(alpha)-methyl-L-tryptophan Chemical group C1=CC=C2C(C[C@H]([NH2+]C)C([O-])=O)=CNC2=C1 CZCIKBSVHDNIDH-NSHDSACASA-N 0.000 abstract 1
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 abstract 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 abstract 1
- 125000000753 cycloalkyl group Chemical group 0.000 abstract 1
- 125000004185 ester group Chemical group 0.000 abstract 1
- 230000002538 fungal effect Effects 0.000 abstract 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract 1
- 125000005473 octanoic acid group Chemical group 0.000 abstract 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/14—Fungi; Culture media therefor
- C12N1/145—Fungal isolates
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K11/00—Depsipeptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K11/02—Depsipeptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof cyclic, e.g. valinomycins ; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/15—Depsipeptides; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/14—Fungi; Culture media therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
- C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/645—Fungi ; Processes using fungi
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Diabetes (AREA)
- Pulmonology (AREA)
- Botany (AREA)
- Biophysics (AREA)
- Biomedical Technology (AREA)
- Virology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Mycology (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Emergency Medicine (AREA)
- Dermatology (AREA)
- Gastroenterology & Hepatology (AREA)
- Epidemiology (AREA)
- Communicable Diseases (AREA)
Abstract
A találmány (I) általánős képletű ciklőpeptőlidőkra vőnatkőzik - ebbena képletben A adőtt esetben a-helyzetben metil-, etil- vagy vinilcsőpőrttalhelyettesített glikőlsavmaradékőt jelent, az a-helyzetű szűbsztitűensadőtt esetben halőgéantőmmal, alkőxicsőpőrttal, adőtt esetben védetthidrőxil- vagy aminőcsőpőrttal, CSNH2-, COOR2-, vinil-, -CCH- vagytiazőlilcsőpőrttal helyettesített, B a-helyzetben aminő-, és g-helyzetben metilcsőpőrtőt tartalmazóőktánsavmaradékőt, R1 hidrőgénatőmőt vagy metilcsőpőrtőt C (II) általánős képletű triptőfán- vagy N-metil-triptőfán-maradékőt, X a-helyzetben aminőcsőpőrttal helyettesített 2-14 szénatőmőskarbőxilsavmaradékőt, és Y a-helyzetben aminő-, vagy N-metil-aminőcsőpőrttal helyettesített 2-10 szénatőmős karbőxilsavmaradékőt jelent, azzal a megszőrítással,hőgy A jelentése szűbsztitűálatlan -a-hidrőxi-vajsav-maradéktóleltérő, és azzal, hőgy ha A jelentése a-helyzetben etilcsőpőrttalhelyettesített glikőlsavmaradék, akkőr az etilcsőpőrt adőtt esetbencsak klóratőmmal, aminő-, hidrőxil-, alkőxi-, adőtt esetbenszűbsztitűált tiazől-, adőtt esetben szűbsztitűált vinil-,ciklőprőpil-, CSNH2 vagy -CCH csőpőrttal lehet helyettesítve. Atalálmány szerinti vegyületek gátőlják az adhéziós mőlekűlákexpresszióját és a TNF felszabadűlását, és mint ilyenekgyűlladásgátló-ként és minden őlyan betegség kezelésére alkalmazhatók,amelyekben az adhéziós mőlekűlák expressziós szintje megnő és/vagyamelyekben a TNF szerepet játszik. ŕ
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9523744.2A GB9523744D0 (en) | 1995-11-21 | 1995-11-21 | Organic compounds |
| GBGB9604406.0A GB9604406D0 (en) | 1996-03-01 | 1996-03-01 | Organic compounds |
| GBGB9613990.2A GB9613990D0 (en) | 1996-07-04 | 1996-07-04 | Organic compounds |
| PCT/EP1996/005123 WO1997019104A1 (en) | 1995-11-21 | 1996-11-20 | Cyclopeptolides |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| HUP9903810A2 true HUP9903810A2 (hu) | 2000-04-28 |
| HUP9903810A3 HUP9903810A3 (en) | 2001-04-28 |
Family
ID=27267982
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU9903810A HUP9903810A3 (en) | 1995-11-21 | 1996-11-20 | Cyclopeptolides |
Country Status (27)
| Country | Link |
|---|---|
| US (1) | US6011136A (hu) |
| EP (1) | EP0866801B1 (hu) |
| JP (1) | JP3463691B2 (hu) |
| KR (1) | KR19990071533A (hu) |
| CN (1) | CN1125079C (hu) |
| AR (1) | AR012286A1 (hu) |
| AT (1) | ATE240972T1 (hu) |
| AU (1) | AU712900B2 (hu) |
| BR (1) | BR9611619B1 (hu) |
| CA (1) | CA2237157C (hu) |
| CO (1) | CO4770985A1 (hu) |
| CZ (1) | CZ154998A3 (hu) |
| DE (1) | DE69628323T2 (hu) |
| ES (1) | ES2200079T3 (hu) |
| HU (1) | HUP9903810A3 (hu) |
| IL (1) | IL124310A0 (hu) |
| MX (1) | MX9804048A (hu) |
| MY (1) | MY115877A (hu) |
| NO (1) | NO982280L (hu) |
| NZ (1) | NZ322909A (hu) |
| PE (1) | PE22998A1 (hu) |
| PL (1) | PL186010B1 (hu) |
| RU (1) | RU2171260C2 (hu) |
| SK (1) | SK65698A3 (hu) |
| TR (1) | TR199800897T2 (hu) |
| TW (1) | TW450978B (hu) |
| WO (1) | WO1997019104A1 (hu) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2002034283A2 (en) * | 2000-10-27 | 2002-05-02 | Novartis Ag | Vegh inhibitors and their use |
| KR20070007336A (ko) * | 2004-03-17 | 2007-01-15 | 노바티스 백신즈 앤드 다이아그노스틱스 인코포레이티드 | 조직인자경로 억제제(ｔｆｐｉ)의 투여에 의한 중증지역사회획득 폐렴의 치료 |
| EP3774850A1 (en) | 2018-03-29 | 2021-02-17 | Kezar Life Sciences | Cdp protein secretion inhibitors |
| CN118319952B (zh) * | 2024-04-09 | 2024-09-20 | 青岛西凯生物技术有限公司 | 一种修复子宫内膜损伤的干细胞制剂及其制备方法 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3832059A1 (de) * | 1988-09-21 | 1990-03-29 | Howaldtswerke Deutsche Werft | Tauchtiefengesteuerte ausblasventil-einrichtung |
| DE3832362A1 (de) * | 1988-09-23 | 1990-03-29 | Sandoz Ag | Neue cyclopeptolide, verfahren zu ihrer herstellung und ihre verwendung |
| AT396108B (de) * | 1991-08-21 | 1993-06-25 | Biochemie Gmbh | Neues verfahren und neue zwischenprodukte zur herstellung von 7-aminocephalosporansaeurederivaten |
| JPH07109299A (ja) * | 1993-10-13 | 1995-04-25 | Shionogi & Co Ltd | 抗ｈｉｖ物質ペスタヒビン及びその誘導体 |
| SK11797A3 (en) * | 1994-07-27 | 1997-07-09 | Sandoz Ltd | Cyclopeptolides, process for their preparation and their use in therapy |
| US20040219569A1 (en) * | 1999-07-06 | 2004-11-04 | Fruma Yehiely | Gene identification method |
-
1996
- 1996-11-11 US US09/068,915 patent/US6011136A/en not_active Expired - Fee Related
- 1996-11-18 AR ARP960105235A patent/AR012286A1/es not_active Application Discontinuation
- 1996-11-19 PE PE1996000830A patent/PE22998A1/es not_active Application Discontinuation
- 1996-11-19 MY MYPI96004794A patent/MY115877A/en unknown
- 1996-11-20 ES ES96939867T patent/ES2200079T3/es not_active Expired - Lifetime
- 1996-11-20 PL PL96326755A patent/PL186010B1/pl unknown
- 1996-11-20 CO CO96061149A patent/CO4770985A1/es unknown
- 1996-11-20 CN CN96198477A patent/CN1125079C/zh not_active Expired - Fee Related
- 1996-11-20 AT AT96939867T patent/ATE240972T1/de not_active IP Right Cessation
- 1996-11-20 CZ CZ981549A patent/CZ154998A3/cs unknown
- 1996-11-20 BR BRPI9611619-6A patent/BR9611619B1/pt not_active IP Right Cessation
- 1996-11-20 RU RU98111936/04A patent/RU2171260C2/ru not_active IP Right Cessation
- 1996-11-20 WO PCT/EP1996/005123 patent/WO1997019104A1/en not_active Application Discontinuation
- 1996-11-20 TW TW085114246A patent/TW450978B/zh not_active IP Right Cessation
- 1996-11-20 HU HU9903810A patent/HUP9903810A3/hu unknown
- 1996-11-20 JP JP51765297A patent/JP3463691B2/ja not_active Expired - Fee Related
- 1996-11-20 AU AU76946/96A patent/AU712900B2/en not_active Ceased
- 1996-11-20 DE DE69628323T patent/DE69628323T2/de not_active Expired - Lifetime
- 1996-11-20 SK SK656-98A patent/SK65698A3/sk unknown
- 1996-11-20 EP EP96939867A patent/EP0866801B1/en not_active Expired - Lifetime
- 1996-11-20 NZ NZ322909A patent/NZ322909A/xx unknown
- 1996-11-20 CA CA002237157A patent/CA2237157C/en not_active Expired - Fee Related
- 1996-11-20 TR TR1998/00897T patent/TR199800897T2/xx unknown
- 1996-11-20 IL IL12431096A patent/IL124310A0/xx unknown
- 1996-11-20 KR KR1019980703806A patent/KR19990071533A/ko not_active Ceased
-
1998
- 1998-05-19 NO NO982280A patent/NO982280L/no not_active Application Discontinuation
- 1998-05-21 MX MX9804048A patent/MX9804048A/es unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2000021927A3 (en) | Pyrrole-2,5-diones as gsk-3 inhibitors | |
| EP0870765A4 (hu) | ||
| WO1999067252A3 (en) | Epothilone derivatives and their synthesis and use | |
| EP0513387A4 (en) | Active oxygen inhibitor | |
| AU3956593A (en) | Perhydroisoindole derivatives as P substance antagonists | |
| LU91112I2 (fr) | Pregabalin, facultativement sous forme d'un sel pharmaceutiquement acceptable. | |
| WO2002026774A3 (en) | Melanocortin receptor ligands | |
| EP0938317A4 (en) | COMPOSITIONS AND METHODS FOR REDUCING RESPIRATORY DEPRESSION | |
| IL164203A0 (en) | Polycyclic compounds as potent alpah2-adrenoceptorantagonists | |
| CA2436848A1 (en) | Coupling process and intermediates useful for preparing cephalosporins | |
| AU8155494A (en) | Methods of increasing thrombomodulin expression | |
| HUP9903810A2 (hu) | Ciklopeptidszármazékok | |
| ZA914747B (en) | Piperidyl-substituted indoles | |
| AU2003235283A1 (en) | Gamma-secretase inhibitors | |
| AU552050B2 (en) | N-substituted azeheterocyclic carboxylic acids and their esters | |
| PL308144A1 (en) | Benzolalkylic acids as active agents against cardiovascular diseases | |
| WO2004054565A8 (en) | Pregabalin and derivates thereof for the treatment of fibromyalgia and other related disorders | |
| EP0627425A4 (hu) | ||
| MXPA02009203A (es) | Proceso para producir camptotecina. | |
| ATE158819T1 (de) | Enzymatische racematspaltung asymmetrischer alkohole mittels vinylestern mehrbasiger carbonsäuren | |
| ZA200002151B (en) | 1-AZA-2-alkyl-6-aryl-cycloalkane compounds, a process for their preparation and pharmaceutical compositions containing them. | |
| WO1998018429A3 (en) | A method for lowering plasma levels of lipoprotein(a) | |
| NZ333769A (en) | A process for preparing naphthyridones and azabicyclo(3.1.0)hexane intermediates for the compound trovafloxacin and derivatives thereof | |
| GEP19970937B (en) | Method of producing derivatives of muramyldipeptide | |
| MX9803479A (es) | Inhibidores de trombina. |